Self-Reinforcing Nanosonosensitizer Boosts Cascade Immune Activation for Refractory Osteomyelitis Treatment and Recurrence Prevention

Osteomyelitis, most commonly caused by methicillin-resistant <i>Staphylococcus aureus</i> (MRSA), remains a formidable clinical challenge due to its chronic progression, immune evasion mechanisms, and resistance to conventional antibiotics. To overcome these barriers, we developed a multifunctional nanoplatform (TMZ) that integrates targeted bacterial eradication with localized immune activation. Trehalose functionalization confers selective recognition of MRSA, thereby enhancing bacterial targeting efficiency. Upon ultrasound irradiation, TMZ generates reactive oxygen species that compromise bacterial membranes and induce immunogenic bacterial death, leading to the release of bacterial DNA and antigens. Concurrently, TMZ undergoes pH-responsive degradation within the acidic osteomyelitis microenvironment, resulting in the controlled release of Mn<sup>2+</sup> ions. These ions act synergistically with bacterial components to activate the cyclic GMP-AMP synthase-stimulator of interferon gene pathway in dendritic cells, thereby promoting innate immune activation, dendritic cell maturation, and efficient antigen presentation. This immune cascade further elicits pathogen-specific adaptive responses and establishes durable immunological memory. <i>In vitro</i> studies showed TMZ exhibited potent bactericidal activity against both planktonic MRSA and mature biofilms. In a murine model of MRSA-induced osteomyelitis, TMZ markedly reduced bacterial burden, activated systemic antibacterial immunity, prevented recurrence, and outperformed conventional antibiotics without inducing resistance. Overall, this work introduces a closed-loop sonodynamic-immune nanotherapy that couples precision bacterial eradication with robust immune activation, offering a promising therapeutic strategy for refractory osteomyelitis and providing new insights into nanomedicine-based immunotherapies for deep-seated bacterial infections.

Authors

Institutions

Publication Details

Journal
ACS Nano
Published
2025-10-24
DOI
https://doi.org/10.1021/acsnano.5c10295
Citations
4
Primary Topic
Orthopedic Infections and Treatments
Type
article
Field-Weighted Citation Impact
8.03
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Self-Reinforcing Nanosonosensitizer Boosts Cascade Immune Activation for Refractory Osteomyelitis Treatment and Recurrence Prevention

Jianwen Hou, Xia Liu, Yuan‐Chien Lin, Shaobing Zhou et al.
4 citations
ACS Nano
Orthopedic Infections and Treatments
8.03
article

Self-Reinforcing Nanosonosensitizer Boosts Cascade Immune Activation for Refractory Osteomyelitis Treatment and Recurrence Prevention

Jianwen Hou, Xia Liu, Yuan‐Chien Lin, Shaobing Zhou, Shuiling Chen, Ming Li, Lixiang Li, Jinying Wu
article en
4 citations

Abstract

Osteomyelitis, most commonly caused by methicillin-resistant <i>Staphylococcus aureus</i> (MRSA), remains a formidable clinical challenge due to its chronic progression, immune evasion mechanisms, and resistance to conventional antibiotics. To overcome these barriers, we developed a multifunctional nanoplatform (TMZ) that integrates targeted bacterial eradication with localized immune activation. Trehalose functionalization confers selective recognition of MRSA, thereby enhancing bacterial targeting efficiency. Upon ultrasound irradiation, TMZ generates reactive oxygen species that compromise bacterial membranes and induce immunogenic bacterial death, leading to the release of bacterial DNA and antigens. Concurrently, TMZ undergoes pH-responsive degradation within the acidic osteomyelitis microenvironment, resulting in the controlled release of Mn<sup>2+</sup> ions. These ions act synergistically with bacterial components to activate the cyclic GMP-AMP synthase-stimulator of interferon gene pathway in dendritic cells, thereby promoting innate immune activation, dendritic cell maturation, and efficient antigen presentation. This immune cascade further elicits pathogen-specific adaptive responses and establishes durable immunological memory. <i>In vitro</i> studies showed TMZ exhibited potent bactericidal activity against both planktonic MRSA and mature biofilms. In a murine model of MRSA-induced osteomyelitis, TMZ markedly reduced bacterial burden, activated systemic antibacterial immunity, prevented recurrence, and outperformed conventional antibiotics without inducing resistance. Overall, this work introduces a closed-loop sonodynamic-immune nanotherapy that couples precision bacterial eradication with robust immune activation, offering a promising therapeutic strategy for refractory osteomyelitis and providing new insights into nanomedicine-based immunotherapies for deep-seated bacterial infections.

ACS NanoVol. 19(43)
Institute of Biomedical Science (GB), Southwest Jiaotong University (CN)
Openalex Percentile: Top 2%
Orthopedic Infections and Treatments
8.03
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.